TG Therapeutics (TGTX) Misses Q4 EPS by 22c

TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), $0.22 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• MotorK names Roy Toren to board as Helen Protopapas resigns
• FactSet Research Systems (FDS) PT Raised to $253 at Jefferies